tiprankstipranks
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market

Alto Neuroscience, Inc. (ANRO) Financial Statements

Compare
99 Followers

Alto Neuroscience, Inc. Financial Overview

Alto Neuroscience, Inc.'s market cap is currently $84.69M. The company's EPS TTM is $-2.133; its P/E ratio is ―; Alto Neuroscience, Inc. is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 210.00K
Gross Profit$ -373.00K$ -342.00K$ 65.00K
Operating Income$ -37.81M$ -29.19M$ -12.06M
EBITDA$ -34.56M$ -27.37M$ -9.04M
Net Income$ -36.30M$ -27.71M$ -9.19M
Balance Sheet
Cash & Short-Term Investments$ 82.55M$ 48.34M$ 25.70M
Total Assets$ 86.63M$ 50.85M$ 28.79M
Total Debt$ 9.99M$ 82.11M$ 38.16M
Net Debt$ -72.56M$ 33.76M$ 12.46M
Total Liabilities$ 158.30M$ 89.26M$ 41.27M
Stockholders' Equity$ -71.67M$ -38.41M$ -12.48M
Cash Flow
Free Cash Flow$ -33.92M$ -21.13M$ -9.94M
Operating Cash Flow$ -33.45M$ -20.39M$ -9.26M
Investing Cash Flow$ -470.00K$ -732.00K$ -680.00K
Financing Cash Flow$ 68.13M$ 43.79M$ 31.69M
Currency in USD

Alto Neuroscience, Inc. Earnings and Revenue History

Alto Neuroscience, Inc. Debt to Assets

Alto Neuroscience, Inc. Cash Flow

Alto Neuroscience, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis